Antacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017 ~ The Lancet Respiratory Medicine in conversation with Podcast

Kerri Johannson from the University of Calgary discusses why
recent treatment guidelines on the use of antacid therapy in
patients with IPF have caused controversy.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Antacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017

Beschreibung

Weitere Episoden

Joan Soriano on Global Epidemiology of Respiratory Disease

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

Laura Garriga-Grimau on bronchiectasis in children and young people

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

Kommentare (0)

Abonnenten

Anmelden mit